|
1
|
Basnyat B and Murdoch DR: High-altitude
illness. Lancet. 361:1967–1974. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
MacInnis MJ, Wang P, Koehle MS and Rupert
JL: The genetics of altitude tolerance: The evidence for inherited
susceptibility to acute mountain sickness. J Occup Environ Med.
53:159–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barry PW and Pollard AJ: Altitude illness.
BMJ. 326:915–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartsch P and Swenson ER: Clinical
practice: Acute high-altitude illnesses. N Engl J Med.
368:2294–2302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schommer K, Bartsch P and Maeder MB: High
Altitude Illness. Notarzt. 29:175–183. 2013.(In German).
|
|
6
|
Schneider M, Bernasch D, Weymann J, Holle
R and Bartsch P: Acute mountain sickness: Influence of
susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc.
34:1886–1891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bigham A, Bauchet M, Pinto D, Mao X, Akey
JM, Mei R, Scherer SW, Julian CG, Wilson MJ, López Herráez D, et
al: Identifying signatures of natural selection in Tibetan and
Andean populations using dense genome scan data. PLoS Genet.
6:e10011162010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beall CM, Cavalleri GL, Deng L, Elston RC,
Gao Y, Knight J, Li C, Li JC, Liang Y, McCormack M, et al: Natural
selection on EPAS1 (HIF2alpha) associated with low hemoglobin
concentration in Tibetan highlanders. Proc Natl Acad Sci USA.
107:11459–11464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng Y, Yang ZH, Zhang H, Cui C, Qi X, Luo
X, Tao X, Wu T, Ouzhuluobu Basang, et al: Genetic variations in
Tibetan populations and high-altitude adaptation at the Himalayas.
Mol Biol Evol. 28:1075–1081. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simonson TS, Yang YZ, Huff CD, Yun H, Qin
G, Witherspoon DJ, Bai Z, Lorenzo FR, Xing J, Jorde LB, et al:
Genetic evidence for high-altitude adaptation in Tibet. Science.
329:72–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yi X, Liang Y, Huerta-Sanchez E, Jin X,
Cuo ZX, Pool JE, Xu X, Jiang H, Vinckenbosch N, Korneliussen TS, et
al: Sequencing of 50 human exomes reveals adaptation to high
altitude. Science. 329:75–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji LD, Qiu YQ, Xu J, Irwin DM, Tam SC,
Tang NL and Zhang YP: Genetic adaptation of the hypoxia-inducible
factor pathway to oxygen pressure among eurasian human populations.
Mol Biol Evol. 29:3359–3370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu S, Li S, Yang Y, Tan J, Lou H, Jin W,
Yang L, Pan X, Wang J, Shen Y, et al: A genome-wide search for
signals of high-altitude adaptation in Tibetans. Mol Biol Evol.
28:1003–1011. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Percy MJ, Furlow PW, Lucas GS, Li X,
Lappin TR, McMullin MF and Lee FS: A gain-of-function mutation in
the HIF2A gene in familial erythrocytosis. N Engl J Med.
358:162–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bougatef F, Quemener C, Kellouche S, Naïmi
B, Podgorniak MP, Millot G, Gabison EE, Calvo F, Dosquet C, Lebbé
C, et al: EMMPRIN promotes angiogenesis through hypoxia-inducible
factor-2alpha-mediated regulation of soluble VEGF isoforms and
their receptor VEGFR-2. Blood. 114:5547–5556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buroker NE, Ning XH, Zhou ZN, Li K, Cen
WJ, Wu XF, Zhu WZ, Scott CR and Chen SH: AKT3, ANGPTL4, eNOS3 and
VEGFA associations with high altitude sickness in Han and Tibetan
Chinese at the Qinghai-Tibetan Plateau. Int J Hematol. 96:200–213.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding H, Liu Q, Hua M, Ding M, Du H, Zhang
W, Li Z and Zhang J: Polymorphisms of hypoxia-related genes in
subjects susceptible to acute mountain sickness. Respiration.
81:236–241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buroker NE, Ning XH, Zhou ZN, Li K, Cen
WJ, Wu XF, Zhu WZ, Scott CR and Chen SH: EPAS1 and EGLN1
associations with high altitude sickness in Han and Tibetan Chinese
at the Qinghai-Tibetan Plateau. Blood Cells Mol Dis. 49:67–73.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roach RC, Bärtsch P, Oelz O and Hachett
PLake Louise AMS Scoring Consensus Committee: The Lake Louise acute
mountain sickness scoring systemSutton JR, Houston CS and Coates G:
Hypoxia and Molecular Medicine. Queen City Printers; Burlington,
VT: pp. 272–274. 1993
|
|
21
|
International HapMap Consortium, . The
International HapMap Project. Nature. 426:789–796. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: Analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Imray C, Booth A, Wright A and Bradwell A:
Acute altitude illnesses. Brit Med J. 343:d49432011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tian H, McKnight SL and Russell DW:
Endothelial PAS domain protein 1 (EPAS1), a transcription factor
selectively expressed in endothelial cells. Genes Dev. 11:72–82.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang BB, Zhang YB, Zhang F, Lin H, Wang X,
Wan N, Ye Z, Weng H, Zhang L, Li X, et al: On the origin of
Tibetans and their genetic basis in adapting high-altitude
environments. PLoS One. 6:e1700222011.
|
|
26
|
Prabhakar NR and Semenza GL: Adaptive and
maladaptive cardiorespiratory responses to continuous and
intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.
Physiol Rev. 92:967–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Desai RJ, Glynn RJ and Gagne JJ:
Performance of disease risk score matching in nested case-control
studies. Pharmacoepidemiol Drug Saf. 23 (Suppl):1482014.
|
|
28
|
Hanaoka M, Droma Y, Basnyat B, Ito M,
Kobayashi N, Katsuyama Y, Kubo K and Ota M: Genetic variants in
EPAS1 contribute to adaptation to high-altitude hypoxia in Sherpas.
PLoS One. 7:e505662012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jensen FB: The dual roles of red blood
cells in tissue oxygen delivery: Oxygen carriers and regulators of
local blood flow. J Exp Biol. 212:3387–3393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hirota K and Semenza GL: Regulation of
angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol.
59:15–26. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Semenza GL: Hypoxia-inducible factors:
Mediators of cancer progression and targets for cancer therapy.
Trends Pharmacol Sci. 33:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
